Michael Wigler

Michael Wigler is an American geneticist renowned for his pioneering work in genomics and cancer biology. A professor at Cold Spring Harbor Laboratory since 1978, his research has fundamentally advanced the understanding of genetic variation and its role in human disease. Wigler is best known for developing key technologies like comparative genomic hybridization and innovative methods for single-cell sequencing, which have transformed the study of cancer genomes and developmental disorders.

Early life and education

Michael Wigler was born in 1947 in New York City. He completed his undergraduate studies in mathematics at Columbia University, earning a Bachelor of Arts degree. He then pursued graduate work in biochemistry at Princeton University, where he conducted his doctoral research under the mentorship of renowned biochemist Arthur B. Pardee. His early academic training at these prestigious institutions provided a strong foundation in quantitative and molecular sciences, which would later define his interdisciplinary approach to biological problems.

Research and career

After completing his Ph.D., Wigler conducted postdoctoral research at the Roche Institute of Molecular Biology. In 1978, he joined the faculty of Cold Spring Harbor Laboratory, a world-renowned center for molecular genetics research, where he has spent the majority of his career. At Cold Spring Harbor Laboratory, he established a research program focused on the molecular biology of mammalian cells and cancer. His laboratory has been instrumental in bridging the gap between basic genetic mechanisms and the complex genetics of human diseases, maintaining long-standing collaborations with institutions like the National Institutes of Health and various academic medical centers.

Major contributions

Wigler's most celebrated contribution is the invention, with colleagues, of comparative genomic hybridization, a pivotal technique for detecting chromosomal copy number variations across entire genomes. This method revolutionized the field of cancer genomics by enabling the systematic discovery of oncogenes and tumor suppressor genes. His laboratory later pioneered powerful methods for single-cell sequencing, allowing for the analysis of genetic heterogeneity within tumors and early embryonic development. These technological innovations have provided critical insights into the genetic causes of autism spectrum disorder, schizophrenia, and various cancers, including breast cancer and lung cancer. His work has also explored the role of mobile genetic elements and retrotransposons in generating somatic mutations.

Awards and honors

In recognition of his transformative research, Michael Wigler has received numerous prestigious awards. He was elected a Member of the National Academy of Sciences in 2004 and a fellow of the American Academy of Arts and Sciences in 2005. A pinnacle of his recognition came in 2013 when he was a co-recipient of the inaugural Breakthrough Prize in Life Sciences, alongside scientists like Cornelia Bargmann and David Botstein. His other honors include the Louisa Gross Horwitz Prize from Columbia University and the Jacob Heskel Gabbay Award in biotechnology.

Personal life

Michael Wigler is known to maintain a private personal life, with public information focused primarily on his scientific career. He has been a central figure in the intellectual community at Cold Spring Harbor Laboratory for decades, mentoring numerous postdoctoral fellows and graduate students who have gone on to prominent positions in academia and industry. His work continues to influence the global direction of biomedical research.

Category:American geneticists Category:Cold Spring Harbor Laboratory faculty Category:National Academy of Sciences members Category:1947 births Category:Living people